• This record comes from PubMed

Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI

. 2021 Aug 01 ; 77 (Pt 8) : 1084-1098. [epub] 20210729

Language English Country United States Media print-electronic

Document type Journal Article

Grant support
HHSN261200800001C CCR NIH HHS - United States
HHSN261200800001E NCI NIH HHS - United States
RVO 61388963 Ústav organické chemie a biochemie Akademie věd České republiky
CZ.02.1.01/0.0/0.0/16_019/0000729 European Regional Development Fund

Links

PubMed 34342281
PubMed Central PMC8329858
DOI 10.1107/s2059798321006483
PII: S2059798321006483
Knihovny.cz E-resources

Structures of BbKI, a recombinant Kunitz-type serine protease inhibitor from Bauhinia bauhinioides, complexed with human kallikrein 4 (KLK4) were determined at medium-to-high resolution in four crystal forms (space groups P3121, P6522, P21 and P61). Although the fold of the protein was virtually identical in all of the crystals, some significant differences were observed in the conformation of Arg64 of BbKI, the residue that occupies the S1 pocket in KLK4. Whereas this residue exhibited two orientations in the highest resolution structure (P3121), making either a canonical trypsin-like interaction with Asp189 of KLK4 or an alternate interaction, only a single alternate orientation was observed in the other three structures. A neighboring disulfide, Cys191-Cys220, was partially or fully broken in all KLK4 structures. Four variants of BbKI in which Arg64 was replaced by Met, Phe, Ala and Asp were expressed and crystallized, and their structures were determined in complex with KLK4. Structures of the Phe and Met variants complexed with bovine trypsin and of the Phe variant complexed with α-chymotrypsin were also determined. Although the inhibitory potency of these variant forms of BbKI was lowered by up to four orders of magnitude, only small changes were seen in the vicinity of the mutated residues. Therefore, a totality of subtle differences in KLK4-BbKI interactions within the fully extended interface in the structures of these variants might be responsible for the observed effect. Screening of the BbKI variants against a panel of serine proteases revealed an altered pattern of inhibitory specificity, which was shifted towards that of chymotrypsin-like proteases for the hydrophobic Phe and Met P1 substitutions. This work reports the first structures of plant Kunitz inhibitors with S1-family serine proteases other than trypsin, as well as new insights into the specificity of inhibition of medically relevant kallikreins.

See more in PubMed

Araújo, A. P. U., Hansen, D., Vieira, D. F., Oliveira, C., Santana, L. A., Beltramini, L. M., Sampaio, C. A. M., Sampaio, M. U. & Oliva, M. L. V. (2005). Biol. Chem. 386, 561–568. PubMed

Bao, R., Zhou, C.-Z., Jiang, C., Lin, S.-X., Chi, C.-W. & Chen, Y. (2009). J. Biol. Chem. 284, 26676–26684. PubMed PMC

Batista, I. F. C., Oliva, M. L. V., Araujo, M. S., Sampaio, M. U., Richardson, M., Fritz, H. & Sampaio, C. A. M. (1996). Phytochemistry, 41, 1017–1022. PubMed

Botos, I. & Wlodawer, A. (2007). Curr. Opin. Struct. Biol. 17, 683–690. PubMed PMC

Brito, M. V., de Oliveira, C., Salu, B. R., Andrade, S. A., Malloy, P. M. D., Sato, A. C., Vicente, C. P., Sampaio, M. U., Maffei, F. H. A. & Oliva, M. L. V. (2014). Thromb. Res. 133, 945–951. PubMed

Burmeister, W. P. (2000). Acta Cryst. D56, 328–341. PubMed

Cereda, V., Formica, V., Menghi, A., Pellicori, S. & Roselli, M. (2015). Expert Opin. Investig. Drugs, 24, 929–947. PubMed

Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson, D. C. (2010). Acta Cryst. D66, 12–21. PubMed PMC

Czapinska, H., Helland, R., Smalås, A. O. & Otlewski, J. (2004). J. Mol. Biol. 344, 1005–1020. PubMed

Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N. M. & Bode, W. (2007). J. Mol. Biol. 373, 1017–1031. PubMed

Debela, M., Hess, P., Magdolen, V., Schechter, N. M., Steiner, T., Huber, R., Bode, W. & Goettig, P. (2007). Proc. Natl Acad. Sci. USA, 104, 16086–16091. PubMed PMC

DeLano, W. L. (2002). PyMOL. http://www.pymol.org.

Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. PubMed PMC

Gong, W., Liu, Y., Seidl, C., Dreyer, T., Drecoll, E., Kotzsch, M., Bronger, H., Dorn, J. & Magdolen, V. (2019). PLoS One, 14, e0212968. PubMed PMC

Helland, R., Czapinska, H., Leiros, I., Olufsen, M., Otlewski, J. & Smalås, A. O. (2003). J. Mol. Biol. 333, 845–861. PubMed

Helland, R., Otlewski, J., Sundheim, O., Dadlez, M. & Smalås, A. O. (1999). J. Mol. Biol. 287, 923–942. PubMed

Horn, M., Zbodakova, O., Kasparek, P., Srp, J., Haneckova, R., Hradilek, M., Mares, M. & Sedlacek, R. (2018). Biol. Chem. 399, 1085–1089. PubMed

Kalinska, M., Meyer-Hoffert, U., Kantyka, T. & Potempa, J. (2016). Biochimie, 122, 270–282. PubMed PMC

Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797. PubMed

Laskowski, M. Jr & Kato, I. (1980). Annu. Rev. Biochem. 49, 593–626. PubMed

Li, M., Srp, J., Gustchina, A., Dauter, Z., Mares, M. & Wlodawer, A. (2019). Acta Cryst. D75, 56–69. PubMed PMC

Lobo, Y. A., Bonazza, C., Batista, F. P., Castro, R. A., Bonturi, C. R., Salu, B. R., de Cassia Sinigaglia, R., Toma, L., Vicente, C. M., Pidde, G., Tambourgi, D. V., Alvarez-Flores, M. P., Chudzinski-Tavassi, A. M. & Oliva, M. L. V. (2020). Cancer Lett. 491, 108–120. PubMed

Majumder, S., Khamrui, S., Dasgupta, J., Dattagupta, J. K. & Sen, U. (2012). Biochim. Biophys. Acta, 1824, 882–890. PubMed

Mavridis, K., Avgeris, M. & Scorilas, A. (2014). Expert Opin. Ther. Targets, 18, 365–383. PubMed

McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. PubMed PMC

Murafuji, H., Sakai, H., Goto, M., Imajo, S., Sugawara, H. & Muto, T. (2017). Bioorg. Med. Chem. Lett. 27, 5272–5276. PubMed

Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. PubMed PMC

Nakahata, A. M., Mayer, B., Neth, P., Hansen, D., Sampaio, M. U. & Oliva, M. L. V. (2013). Planta Med. 79, 227–235. PubMed

Nishimiya, D., Kawaguchi, Y., Kodama, S., Nasu, H., Yano, H., Yamaguchi, A., Tamura, M. & Hashimoto, R. (2019). Sci. Rep. 9, 11436. PubMed PMC

Odei-Addo, F., Frost, C., Smith, N., Ogawa, T., Muramoto, K., Oliva, M. L. V., Gráf, L. & Naude, R. (2014). J. Enzyme Inhib. Med. Chem. 29, 633–638. PubMed

Oliva, M. L. V., Mendes, C. R., Juliano, M. A., Chagas, J. R., Rosa, J. C., Greene, L. J., Sampaio, M. U. & Sampaio, C. A. M. (1999). Immunopharmacology, 45, 163–169. PubMed

Oliva, M. L. V., Mendes, C. R., Santomauro-Vaz, E. M., Juliano, M. A., Mentele, R., Auerswald, E. A., Sampaio, M. U. & Sampaio, C. A. M. (2001). Curr. Med. Chem. 8, 977–984. PubMed

Oliva, M. L. V. & Sampaio, U. M. (2008). Biol. Chem. 389, 1007–1013. PubMed

Oliva, M. L. V., Silva, M. C. C., Sallai, R. C., Brito, M. V. & Sampaio, M. U. (2010). Biochimie, 92, 1667–1673. PubMed

Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. PubMed

Pampalakis, G. & Sotiropoulou, G. (2007). Biochim. Biophys. Acta, 1776, 22–31. PubMed

Patil, D. N., Chaudhary, A., Sharma, A. K., Tomar, S. & Kumar, P. (2012). FEBS J. 279, 4547–4564. PubMed

Prassas, I., Eissa, A., Poda, G. & Diamandis, E. P. (2015). Nat. Rev. Drug Discov. 14, 183–202. PubMed

Ravelli, R. B. G. & McSweeney, S. M. (2000). Structure, 8, 315–328. PubMed

Renko, M., Sabotič, J. & Turk, D. (2012). Biol. Chem. 393, 1043–1054. PubMed

Riley, B. T., Hoke, D. E., McGowan, S. & Buckle, A. M. (2019). Acta Cryst. F75, 543–546. PubMed PMC

Riley, B. T., Ilyichova, O., Costa, M. G., Porebski, B. T., de Veer, S. J., Swedberg, J. E., Kass, I., Harris, J. M., Hoke, D. E. & Buckle, A. M. (2016). Sci. Rep. 6, 35385. PubMed PMC

Riley, B. T., Ilyichova, O., de Veer, S. J., Swedberg, J. E., Wilson, E., Hoke, D. E., Harris, J. M. & Buckle, A. M. (2019). Biochemistry, 58, 2524–2533. PubMed

Shelley, K. L., Dixon, T. P. E., Brooks-Bartlett, J. C. & Garman, E. F. (2018). J. Appl. Cryst. 51, 552–559. PubMed PMC

Song, H. K. & Suh, S. W. (1998). J. Mol. Biol. 275, 347–363. PubMed

Sotiropoulou, G. & Pampalakis, G. (2012). Trends Pharmacol. Sci. 33, 623–634. PubMed

Souza-Pinto, J. C., Oliva, M. L., Sampaio, C. A., Damas, J., Auerswald, E. A., Limaos, E., Fritz, H. & Sampaio, M. U. (1996). Immuno­pharmacology, 33, 330–332. PubMed

Turk, B. (2006). Nat. Rev. Drug Discov. 5, 785–799. PubMed

Vadivel, K., Ponnuraj, S. M., Kumar, Y., Zaiss, A. K., Bunce, M. W., Camire, R. M., Wu, L., Evseenko, D., Herschman, H. R., Bajaj, M. S. & Bajaj, S. P. (2014). J. Biol. Chem. 289, 31647–31661. PubMed PMC

Weik, M., Ravelli, R. B., Kryger, G., McSweeney, S., Raves, M. L., Harel, M., Gros, P., Silman, I., Kroon, J. & Sussman, J. L. (2000). Proc. Natl Acad. Sci. USA, 97, 623–628. PubMed PMC

Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A. & Wilson, K. S. (2011). Acta Cryst. D67, 235–242. PubMed PMC

Zhou, D., Hansen, D., Shabalin, I. G., Gustchina, A., Vieira, D. F., de Brito, M. V., Araújo, A. P. U., Oliva, M. L. V. & Wlodawer, A. (2015). Acta Cryst. F71, 1055–1062. PubMed PMC

Zhou, D., Lobo, Y. A., Batista, I. F., Marques-Porto, R., Gustchina, A., Oliva, M. L. & Wlodawer, A. (2013). PLoS One, 8, e62252. PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...